| Chapter title |
Prescription Treatment Options
|
|---|---|
| Chapter number | 10 |
| Book title |
Management of Atopic Dermatitis
|
| Published in |
Advances in experimental medicine and biology, January 2017
|
| DOI | 10.1007/978-3-319-64804-0_10 |
| Pubmed ID | |
| Book ISBNs |
978-3-31-964803-3, 978-3-31-964804-0
|
| Authors |
Brad Ackerson, Ryan Thorpe, Matilda W. Nicholas |
| Abstract |
Atopic dermatitis frequently requires the use of over-the-counter and prescription medications for effective management. Emollients and topical corticosteroids are effective for most patients and are the most commonly utilized agents by experienced dermatologists. Antihistamines, antibiotics, and calcineurin inhibitors may also prove helpful in the correct clinical scenarios. Severe atopic dermatitis, however, can be difficult to manage and not infrequently require substantial immunomodulatory medications. Targeted molecular therapies, such as dupilumab, are promising, emerging atopic dermatitis therapies. The medication pearls reviewed in this chapter will assist providers in managing atopic dermatitis patients. |
Mendeley readers
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Argentina | 1 | 5% |
| Unknown | 19 | 95% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 3 | 15% |
| Student > Postgraduate | 3 | 15% |
| Student > Bachelor | 2 | 10% |
| Librarian | 2 | 10% |
| Student > Master | 2 | 10% |
| Other | 4 | 20% |
| Unknown | 4 | 20% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 9 | 45% |
| Agricultural and Biological Sciences | 2 | 10% |
| Biochemistry, Genetics and Molecular Biology | 1 | 5% |
| Psychology | 1 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 1 | 5% |
| Other | 0 | 0% |
| Unknown | 6 | 30% |